Zacks Research Has Weak Forecast for Danaher FY2024 Earnings

Danaher Co. (NYSE:DHR) – Stock analysts at Zacks Research lowered their FY2024 earnings per share (EPS) estimates for shares of Danaher in a research note issued to investors on Tuesday, November 12th. Zacks Research analyst R. Department now expects that the conglomerate will post earnings per share of $7.49 for the year, down from their prior estimate of $7.56. The consensus estimate for Danaher’s current full-year earnings is $7.51 per share. Zacks Research also issued estimates for Danaher’s Q4 2024 earnings at $2.14 EPS, Q1 2025 earnings at $2.05 EPS, Q2 2025 earnings at $1.91 EPS, Q3 2025 earnings at $1.94 EPS, Q4 2025 earnings at $2.34 EPS, FY2025 earnings at $8.24 EPS, Q1 2026 earnings at $2.21 EPS, Q2 2026 earnings at $2.25 EPS and FY2026 earnings at $9.28 EPS.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.14. The business had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same quarter last year, the business earned $2.02 earnings per share.

A number of other equities analysts have also recently issued reports on DHR. Robert W. Baird reduced their price objective on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Evercore ISI lifted their price objective on Danaher from $275.00 to $278.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 1st. KeyCorp upped their price objective on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. StockNews.com upgraded Danaher from a “hold” rating to a “buy” rating in a report on Wednesday, November 6th. Finally, Stifel Nicolaus upped their price target on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research note on Wednesday, October 23rd. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $287.16.

Danaher Stock Down 0.9 %

Shares of NYSE DHR opened at $239.45 on Thursday. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $172.95 billion, a PE ratio of 46.08, a price-to-earnings-growth ratio of 4.40 and a beta of 0.85. The firm’s 50-day moving average is $263.42 and its 200-day moving average is $260.64. Danaher has a 1 year low of $204.15 and a 1 year high of $281.70.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in DHR. CarsonAllaria Wealth Management Ltd. acquired a new position in shares of Danaher during the 2nd quarter worth about $25,000. nVerses Capital LLC acquired a new stake in shares of Danaher in the second quarter valued at about $25,000. Teachers Insurance & Annuity Association of America bought a new stake in Danaher during the third quarter worth about $39,000. MidAtlantic Capital Management Inc. acquired a new position in Danaher during the third quarter valued at approximately $40,000. Finally, FSA Wealth Management LLC bought a new position in Danaher in the third quarter valued at approximately $50,000. Institutional investors own 79.05% of the company’s stock.

Insider Transactions at Danaher

In other news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the sale, the senior vice president now directly owns 4,212 shares in the company, valued at $1,130,374.44. This trade represents a 18.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 11.10% of the stock is owned by insiders.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were issued a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. Danaher’s dividend payout ratio (DPR) is 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.